Rare diseases
Investigational molecules
Locations
-, 151 85 Sodertalje, Sweden
Oncology is the central area of research interest, with extensive activity across breast cancer, non-small cell lung cancer, ovarian cancer, prostate cancer, bladder cancer, gastric cancer, gastroesophageal junction adenocarcinoma, hepatocellular carcinoma, biliary tract cancer, pancreatic cancer, head and neck squamous cell carcinoma, and pleural mesothelioma. The sponsor also studies hematologic malignancies including chronic lymphocytic leukemia, mantle cell lymphoma, large B-cell lymphoma, multiple myeloma, acute leukemia, and myelodysplastic syndromes.
Research also includes advanced solid tumors with specific molecular features such as BRCA alterations, HER2 expression, PD-L1 expression, MET drive, CLDN18.2 expression, and other actionable genomic changes.
AstraZeneca AB runs clinical trials in conditions such as Non-small cell lung cancer, Asthma, Chronic obstructive pulmonary disease, Breast cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
A Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
BulgariaSafety and Tolerability of Benralizumab in Patients with HES, EGPA, or Asthma Who Completed a Prior Study
AustriaA study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
CzechiaRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
BulgariaA Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus
BulgariaEvaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus
FrancePhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
AustriaStudy of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
BulgariaStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
BulgariaBulgariaStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
BelgiumStudy on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
